25K DCF Valuation - Karyopharm Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 4.74 EUR 1.72% Market Closed

Market Cap: €2.4B

K	Karyopharm Therapeutics Inc SWB:25K	US
	888 Holdings PLC LSE:EVOK	GI
S	secunet Security Networks AG DUS:YSN	DE
O	OUTFRONT Media Inc F:76C	US
B	Bic Camera Inc F:1U3	JP
A	Accenture PLC BMV:ACNN	IE
D	Dollar General Corp SWB:7DG	US
C	China Shenhua Energy Co Ltd XHAM:IKF	CN
A	Apple Inc MIL:AAPL	US
	Mettler-Toledo International Inc NYSE:MTD	US
A	Alpha Pro Tech Ltd SWB:APL	CA
	Baxter International Inc NYSE:BAX	US
S	Sirona Biochem Corp SWB:ZSB	CA
S	Suncor Energy Inc XMUN:SM3	CA
C	Cheerwin Group Ltd F:1RQ	CN
S	SAP SE DUS:SAP	DE
	Raymond Ltd BSE:500330	IN
A	Arbor Realty Trust Inc XBER:OWQ	US
	Electrosteel Castings Ltd NSE:ELECTCAST	IN
D	Datang International Power Generation Co Ltd OTC:DIPGF	CN

25K's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.